StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) stock

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$413.26+1.97 (+0.48%)

Close on Nov 17, 2026Market cap $46.99BP/E 73.9Yield –

BeOne Medicines pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

BeOne Medicines's pe ratio was 75.1× on Nov 11, 2026, against 873.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202675.1×−703.9
2025Dec 31, 2025779.0×–

More BeOne Medicines figures

See a number that looks wrong?